Differences between the efficacy of HER2(2+)/FISH-positive and HER2(3+) in breast cancer during dual-target neoadjuvant therapy

INTRODUCTION: This study investigated the differences in efficacy between IHC(2+)/FISH-positive and IHC(3+) in HER2-positive breast cancer (BC) during neoadjuvant chemotherapy (NAC) combined with trastuzumab and pertuzumab. The research also aimed to provide insight into treatment strategies for cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Li, Fen-Xiang, Lu, Da-Lin, Jiang, Jun, Li, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400900/
https://www.ncbi.nlm.nih.gov/pubmed/37517155
http://dx.doi.org/10.1016/j.breast.2023.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400900/
https://www.ncbi.nlm.nih.gov/pubmed/37517155
http://dx.doi.org/10.1016/j.breast.2023.07.008

Ejemplares similares